Literature DB >> 2808671

Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.

P C Fuchs1, R N Jones, A L Barry.   

Abstract

There are at least four different existing or proposed interpretive criteria for the disk diffusion susceptibility testing of ticarcillin and ticarcillin plus clavulanic acid (T/C). To assess these criteria, 570 gram-negative bacillary isolates were tested for susceptibility to ticarcillin and T/C by both disk diffusion and broth microdilution methods. These included 53 strains of the family Enterobacteriaceae selected for ticarcillin resistance and high-level beta-lactamase production. The broth microdilution test results were more influenced by increased beta-lactamase production than were disk diffusion results. In the absence of published data indicating which of the two standardized test methods better predicts clinical response, we conclude that until such data are available the more conservative National Committee for Clinical Laboratory Standards tentative criteria for tests with members of the Enterobacteriaceae are appropriate. Our data do not support the use of separate T/C interpretive criteria for Pseudomonas spp. and members of the Enterobacteriaceae. The appropriateness of different interpretive criteria needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808671      PMCID: PMC267061          DOI: 10.1128/jcm.27.11.2475-2481.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.

Authors:  C C Sanders; J P Iaconis; G P Bodey; G Samonis
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

2.  Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.

Authors:  J W Paisley; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

3.  Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.

Authors:  P C Fuchs; R N Jones; A L Barry; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

4.  In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.

Authors:  P C Fuchs; A L Barry; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

5.  In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.

Authors:  D Henry; A G Skidmore; J Ngui-Yen; A Smith; J A Smith
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

6.  Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.

Authors:  E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

7.  Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections.

Authors:  W T Siebert; P E Kopp
Journal:  Am J Med       Date:  1985-11-29       Impact factor: 4.965

8.  Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.

Authors:  W J Holloway
Journal:  Am J Med       Date:  1985-11-29       Impact factor: 4.965

  8 in total
  4 in total

1.  Failure to adopt new interpretive criteria for ticarcillin-clavulanic acid could prove fatal.

Authors:  C C Sanders; W E Sanders; K S Thomson; S J Cavalieri
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards.

Authors:  J A Washington
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

3.  Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae.

Authors:  A L Barry; P C Fuchs; E H Gerlach; D J Hardy; J C McLaughlin; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

4.  Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strains.

Authors:  C C Sanders; S J Cavalieri
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.